Lenalidomide in combination with bendamustine and prednisolone in relapsed/refractory multiple myeloma: results of a phase 2 clinical trial (OSHO-#077).

about

Artemisinin and Its Synthetic Derivatives as a Possible Therapy for Cancer.

P2860

Q55404606-CCE5A1D6-2422-4DF1-AF41-60CD636A903C

P2860

Lenalidomide in combination with bendamustine and prednisolone in relapsed/refractory multiple myeloma: results of a phase 2 clinical trial (OSHO-#077).

Item

http://www.wikidata.org/entity/Q48204298

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Lenalidomide in combination wi ...... 2 clinical trial (OSHO-#077).

@en

Lenalidomide in combination wi ...... ts of a phase 2 clinical trial

@nl

type

Item

label

Lenalidomide in combination wi ...... 2 clinical trial (OSHO-#077).

@en

Lenalidomide in combination wi ...... ts of a phase 2 clinical trial

@nl

prefLabel

Lenalidomide in combination wi ...... 2 clinical trial (OSHO-#077).

@en

Lenalidomide in combination wi ...... ts of a phase 2 clinical trial

@nl

P1476

Lenalidomide in combination wi ...... e 2 clinical trial (OSHO-#077)

@en

P2093

Andreas Schwarzer

http://www.w3.org/2001/XMLSchema#string

Brigitte Kragl

http://www.w3.org/2001/XMLSchema#string

Cornelia Becker

http://www.w3.org/2001/XMLSchema#string

Cornelia Winkelmann

http://www.w3.org/2001/XMLSchema#string

Dietger Niederwieser

http://www.w3.org/2001/XMLSchema#string

Dietrich Gläser

http://www.w3.org/2001/XMLSchema#string

Franz Albert Hoffmann

http://www.w3.org/2001/XMLSchema#string

Jens Uhlig

http://www.w3.org/2001/XMLSchema#string

Juliane Beck

http://www.w3.org/2001/XMLSchema#string

Lars-Olof Mügge

http://www.w3.org/2001/XMLSchema#string

P2860

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

Combined bendamustine, prednisolone and thalidomide for refractory or relapsed multiple myeloma after autologous stem-cell transplantation or conventional chemotherapy: results of a Phase I clinical trial.

Lenalidomide, adriamycin, and dexamethasone (RAD) in patients with relapsed and refractory multiple myeloma: a report from the German Myeloma Study Group DSMM (Deutsche Studiengruppe Multiples Myelom).

Safety and efficacy of single-agent lenalidomide in patients with relapsed and refractory multiple myeloma.

Combination of bendamustine, lenalidomide, and dexamethasone (BLD) in patients with relapsed or refractory multiple myeloma is feasible and highly effective: results of phase 1/2 open-label, dose escalation study.

Phase I/II trial assessing bendamustine plus bortezomib combination therapy for the treatment of patients with relapsed or refractory multiple myeloma.

Combined bendamustine, prednisone and bortezomib (BPV) in patients with relapsed or refractory multiple myeloma.

Bendamustine-bortezomib-dexamethasone is an active and well-tolerated regimen in patients with relapsed or refractory multiple myeloma.

Efficacy and tolerability of bendamustine, bortezomib and dexamethasone in patients with relapsed-refractory multiple myeloma: a phase II study.

Bendamustine in combination with thalidomide and dexamethasone is a viable salvage option in myeloma relapsed and/or refractory to bortezomib and lenalidomide.

P2888

s00432-017-2504-5

P304

2545-2553

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00432-017-2504-5

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

143

http://www.w3.org/2001/XMLSchema#string

P50

Wolfram Pönisch

P577

2017-08-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28828689

http://www.w3.org/2001/XMLSchema#string

P921

phase II clinical trial

Lenalidomide in combination with bendamustine and prednisolone in relapsed/refractory multiple myeloma: results of a phase 2 clinical trial (OSHO-#077).

about

P2860

P2860

Lenalidomide in combination with bendamustine and prednisolone in relapsed/refractory multiple myeloma: results of a phase 2 clinical trial (OSHO-#077).

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921